Quantum dots have shown promise in a variety of imaging and therapeutic applications, particularly when they are coated to render them biocompatible. However, such coating can increase the size of quantum dots signficantly, which can adversely effect their pharmacokinetic and biodistribution properties.
Now, researchers at the Massachussetts Institute of Technology and Beth Israel Deaconess Medical Center have developed a new procedure that produces ultracompact quantum dots. Tests with these new materials show that this coating not only does not impair the superior optical properties of the quantum dots but also improves how the quantum dots behave in living animals.
Moungi Bawendi, Ph.D., a member of the MIT-Harvard Center of Cancer Nanotechnology Excellence, and John Frangioni, M.D., Ph.D., led this study. Their results appear in the
Journal of the American Chemical Society.
To create these compact quantum dots, the investigators first create dual-layer nanocrystals that have a zinc-cadmium-sulfide (ZnCdS) core surrounded by a cadmium selenide (CdSe) shell. This combination of materials creates a compact yet bright quantum dot. Next, the researchers add a coating of cysteine, a sulfur-containing amino acid that binds tightly to the CdSe shell.
When stored in the presence of a reducing agent, these quantum dots are stable for 1 week at room temperature and at least 3 months at 4°C. Dynamic light scattering, a technique used to study nanoparticle size, showed that the diameter of these quantum dots was 5.9 nanometers. More importantly, their size did not increase when incubated with serum, demonstrating that the cysteine coating prevented proteins from collecting on the quantum dot surface.
The researchers note that the exceptionally small size of their quantum dots and their stability in serum led to new in vivo behavior. When injected into rats, the majority of the quantum dots accumulated in the bladder within 4 hours, demonstrating that these nanoparticles are small enough to be filtered out of the kidneys. In practical terms, this finding suggests that these compact quantum dots, if attached to a small targeting molecule, could be used to image tumors without having to worry about accumulation within the body. Any injected dose that did not bind to its target would clear rapidly, decreasing background noise and improving the sensitivity of tumor imaging.
This work, which was supported in part by the National Cancer Institute’s Alliance for Nanotechnology in Cancer, is detailed in the paper "Compact cysteine-coated CdSe(ZnCdS) quantum dots for in vivo applications." This paper was published online in advance of print publication. An abstract of this paper is available
through PubMed.
Source: National Cancer Institute
Related stories:
When particles are so small that they seep right through skin
Scientists are finding that particles that are barely there – tiny objects known as nanoparticles that have found a home in electronics, food containers, sunscreens, and a variety of applications – can breech our most personal protective barrier: The skin.
Scientists develop new, more sensitive nanotechnology test for chemical DNA modifications
Researchers at The Johns Hopkins University School of Medicine in Baltimore have developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies.
Scientists take the sharpest image ever made with light
(PhysOrg.com) -- A team of scientists from the Technische Universität Dresden (Germany) and the ESRF in Grenoble (France) has produced the image of an object at the highest resolution ever achieved with X-ray light. A 100-nanometre gold particle fixed on a substrate was reconstructed with 5 nanometre resolution. Contrary to other techniques, X-ray imaging works also in real-life environments like chemical processing or in the presence of high magnetic fields. The team reports its findings in the newest issue of
Phys. Rev. Lett. dated 5 September 2008 (published online 29 August 2008).
First reported video of cell's recognition of danger through its protein response
(PhysOrg.com) -- Cells are expected to respond defensively when an antigen lands on a cell membrane and prepares to cause mischief.
Improving Quantum Dot Synthesis
Materials researchers at the National Institute of Standards and Technology have developed a simplified, low-cost process for producing high-quality, water-soluble quantum dots for biomedical applications. By using a laboratory microwave reactor to promote the synthesis of the widely used nanomaterials, the recently published NIST process avoids a problematic step in the conventional approach to making quantum dots, resulting in brighter, more stable dots.
Study shows quantum dots can penetrate skin through minor abrasions
Researchers at North Carolina State University have found that quantum dot nanoparticles can penetrate the skin if there is an abrasion, providing insight into potential workplace concerns for healthcare workers or individuals involved in the manufacturing of quantum dots or doing research on potential biomedical applications of the tiny nanoparticles.
New paper offers insights into 'blinking' phenomena
A new paper by a team of researchers led by University of Notre Dame physicist Bolizsár Jankó provides an overview of research into one of the few remaining unsolved problems of quantum mechanics.
Gene silencer and quantum dots reduce protein production to a whisper
More than 15 years ago scientists discovered a way to stop a particular gene in its tracks. The Nobel Prize-winning finding holds tantalizing promise for medical science, but so far it has been difficult to apply the technique, known as RNA interference, in living cells.